Analystreport

NeuBase Therapeutics, Inc. (NASDAQ: NBSE) had its "buy" rating re-affirmed by analysts at HC Wainwright.

NeuBase Therapeutics, Inc.  (NBSE) 
Last neubase therapeutics, inc. earnings: 3/26 04:05 pm Check Earnings Report